Atika Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-85,000
| Closed | -$8.2M | – | 90 |
|
|
2023
Q4 | $8.2M | Buy |
+85,000
| New | +$8.2M | 1.1% | 34 |
|
|
2023
Q1 | – | Sell |
-73,739
| Closed | -$7.63M | – | 73 |
|
|
2022
Q4 | $7.63M | Buy |
+73,739
| New | +$7.63M | 1.1% | 35 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 86 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 83 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 92 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 92 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 84 |
|
|
2020
Q1 | – | Sell |
-18,000
| Closed | -$1.52M | – | 77 |
|
|
2019
Q4 | $1.52M | Buy |
+18,000
| New | +$1.52M | 0.29% | 62 |
|
|
2019
Q2 | – | Sell |
-34,500
| Closed | -$3.06M | – | 73 |
|
|
2019
Q1 | $3.06M | Buy |
34,500
+500
| +1% | +$44.4K | 0.62% | 48 |
|
|
2018
Q4 | $2.9M | Buy |
+34,000
| New | +$2.9M | 0.85% | 37 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 75 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 71 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 64 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 69 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 64 |
|
|
2016
Q4 | – | Sell |
-35,000
| Closed | -$3.24M | – | 59 |
|
|
2016
Q3 | $3.24M | Buy |
+35,000
| New | +$3.24M | 1.32% | 24 |
|
|
2016
Q2 | – | Sell |
-24,000
| Closed | -$1.98M | – | 56 |
|
|
2016
Q1 | $1.98M | Buy |
24,000
+22,000
| +1,100% | +$1.82M | 1.2% | 32 |
|
|
2015
Q4 | $210K | Sell |
2,000
-30,000
| -94% | -$3.15M | 0.11% | 51 |
|
|
2015
Q3 | $3.37M | Buy |
+32,000
| New | +$3.37M | 1.65% | 17 |
|
|
2015
Q1 | – | Sell |
-8,000
| Closed | -$723K | – | 60 |
|
|
2014
Q4 | $723K | Buy |
+8,000
| New | +$723K | 0.53% | 52 |
|